Peptide Safety & Harm Reduction

Research peptides carry inherent risks. This guide covers the major safety considerations for anyone involved in peptide research, with emphasis on minimizing harm through proper sourcing, handling, and awareness.

Sourcing Risks

The single largest safety risk is compound quality. Unverified suppliers may sell underdosed, substituted, or contaminated products. Mitigation: only source from vendors with independently verified COAs. QSC Peptides publishes Janoshik-independent COAs on every product page. Learn how to read a COA →

Injection Hygiene

• Always use new, sterile syringes for each injection
• Swab vial tops and injection sites with alcohol
• Never share syringes or multi-dose vials between users
• Rotate injection sites to prevent lipodystrophy
• Dispose of sharps in proper containers

Reconstitution Safety

Use bacteriostatic water (not sterile water) for reconstitution — the 0.9% benzyl alcohol preservative prevents microbial growth. Never inject water directly onto lyophilized powder (inject down the vial wall). Never shake — swirl gently. Full reconstitution guide →

Storage

Lyophilized peptides: refrigerate or freeze. Reconstituted peptides: refrigerate at 2–8°C, use within 2–4 weeks. Oil injectables: room temperature. Never expose to direct sunlight. Full storage guide →

Compound Interactions

Multi-compound protocols create interaction complexity. Key considerations: GLP-1 agonists (retatrutide) can delay gastric emptying, affecting absorption of oral compounds; testosterone and anavar both impact liver values; NAD+ and glutathione compete for some metabolic pathways but are complementary at standard research doses; BPC-157's NO modulation may affect blood pressure in combination with other vasoactive compounds.

Counterfeit Detection

• Request and verify COA before use (Janoshik verification at verify.janoshik.com)
• Check lyophilized appearance: should be a white/off-white solid cake or powder
• Yellowing, liquid, or collapsed cake may indicate degradation
• Verify vial labels match COA batch numbers

When to Stop

Discontinue research and consult a medical professional if observing: persistent injection site reactions, unexpected cardiovascular symptoms, jaundice or liver-related symptoms, severe GI distress, or any allergic reactions.

Medical experts warn against unsupervised compound use. All products referenced on this site are for laboratory research only.